Atlas Trials

Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma

Clinical trial NCT05563922 · RECRUITING

Trial details

NCT number
NCT05563922
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2022-09-01
Primary completion
2025-08-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.